Terms: = Brain cancer AND CARS, P49589, 833, ENSG00000110619
138 results:
1. CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment.
Kong D; Kwon D; Moon B; Kim DH; Kim MJ; Choi J; Kang KS
Biomed Pharmacother; 2024 May; 174():116436. PubMed ID: 38508081
[TBL] [Abstract] [Full Text] [Related]
2. Identifying key factors for predicting O6-Methylguanine-DNA methyltransferase status in adult patients with diffuse glioma: a multimodal analysis of demographics, radiomics, and MRI by variable Vision Transformer.
Usuzaki T; Takahashi K; Inamori R; Morishita Y; Shizukuishi T; Takagi H; Ishikuro M; Obara T; Takase K
Neuroradiology; 2024 May; 66(5):761-773. PubMed ID: 38472373
[TBL] [Abstract] [Full Text] [Related]
3. A second-generation M1-polarized CAR macrophage with antitumor efficacy.
Lei A; Yu H; Lu S; Lu H; Ding X; Tan T; Zhang H; Zhu M; Tian L; Wang X; Su S; Xue D; Zhang S; Zhao W; Chen Y; Xie W; Zhang L; Zhu Y; Zhao J; Jiang W; Church G; Chan FK; Gao Z; Zhang J
Nat Immunol; 2024 Jan; 25(1):102-116. PubMed ID: 38012418
[TBL] [Abstract] [Full Text] [Related]
4. Ultra high b-value diffusion weighted imaging enables better molecular grading stratification over histological grading in adult-type diffuse glioma.
Guo J; Fu X; Li Y; Ming H; Lin Y; Yu S; Wei H; Sun C; Zhang K; Yang X
Eur J Radiol; 2023 Nov; 168():111140. PubMed ID: 37832200
[TBL] [Abstract] [Full Text] [Related]
5. Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
Kuan AS; Chiang CL; Wu HM; Yang HC; Chen CJ; Lin CJ; Guo WY; Pan DH; Chung WY; Lee CC
J Neurooncol; 2023 Sep; 164(3):729-739. PubMed ID: 37721662
[TBL] [Abstract] [Full Text] [Related]
6. Preoperative vascular heterogeneity based on dynamic susceptibility contrast MRI in predicting spatial pattern of locally recurrent high-grade gliomas.
Wang H; Zeng L; Wu H; Tian J; Xie H; Zhang L; Ran Q; Zhong P; Chen L; Yi L; Wang S
Eur Radiol; 2024 Mar; 34(3):1982-1993. PubMed ID: 37658897
[TBL] [Abstract] [Full Text] [Related]
7. Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma.
Restle D; Dux J; Li X; Byun AJ; Choe JK; Li Y; Vaghjiani RG; Thomas C; Misawa K; Tan KS; Jones DR; Chintala NK; Adusumilli PS
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37349126
[TBL] [Abstract] [Full Text] [Related]
8. IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy.
Gu A; Bai Y; Zhang C; Xu C; An Z; Zhang Y; Zhong SH; Hu Y; Zhong X
Cancer Immunol Immunother; 2023 Jul; 72(7):2393-2403. PubMed ID: 36991262
[TBL] [Abstract] [Full Text] [Related]
9. Quantitative proteomics identified a novel invasion biomarker associated with EMT in pituitary adenomas.
Zhang Y; Li L; Ma X; Liu C; Liu G; Bie Z; Yang Z; Liu P
Front Endocrinol (Lausanne); 2023; 14():1137648. PubMed ID: 36936141
[TBL] [Abstract] [Full Text] [Related]
10. Raman Spectroscopy as a Tool to Study the Pathophysiology of brain Diseases.
Terrones O; Olazar-Intxausti J; Anso I; Lorizate M; Nieto-Garai JA; Contreras FX
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768712
[TBL] [Abstract] [Full Text] [Related]
11. Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast cancer brain Metastases.
Jenkins S; Zhang W; Steinberg SM; Nousome D; Houston N; Wu X; Armstrong TS; Burton E; Smart DD; Shah R; Peer CJ; Mozarsky B; Arisa O; Figg WD; Mendoza TR; Vera E; Brastianos P; Carter S; Gilbert MR; Anders CK; Connolly RM; Tweed C; Smith KL; Khan I; Lipkowitz S; Steeg PS; Zimmer AS
Clin Cancer Res; 2023 Apr; 29(8):1450-1459. PubMed ID: 36705597
[TBL] [Abstract] [Full Text] [Related]
12. MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients.
Ferrer VP
Cancer Genet; 2023 Jan; 270-271():22-30. PubMed ID: 36436416
[TBL] [Abstract] [Full Text] [Related]
13. Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.
Cui Y; Shi X; Wang S; Qin Y; Wang B; Che X; Lei M
Front Public Health; 2022; 10():1019168. PubMed ID: 36276398
[TBL] [Abstract] [Full Text] [Related]
14. Radiomic study on preoperative multi-modal magnetic resonance images identifies IDH-mutant TERT promoter-mutant gliomas.
Wang H; Zhang S; Xing X; Yue Q; Feng W; Chen S; Zhang J; Xie D; Chen N; Liu Y
Cancer Med; 2023 Feb; 12(3):2524-2537. PubMed ID: 36176070
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic yield of diffusion-weighted brain MR imaging in patients with cognitive impairment: Large cohort study with 3,298 patients.
Kim M; Kim SY; Suh CH; Shim WH; Lee JH; Guenette JP; Huang RY; Kim SJ
PLoS One; 2022; 17(9):e0274795. PubMed ID: 36136975
[TBL] [Abstract] [Full Text] [Related]
16. The correlations between psychological distress, cognitive impairment and quality of life in patients with brain metastases after whole-brain radiotherapy.
Yao S; Zuo H; Li W; Cai Y; Zhang Q; Pang L; Jing Y; Yin X; Cheng H
Clin Transl Oncol; 2023 Jan; 25(1):207-217. PubMed ID: 36038750
[TBL] [Abstract] [Full Text] [Related]
17. MTDCNet: A 3D multi-threading dilated convolutional network for brain tumor automatic segmentation.
Chen W; Zhou W; Zhu L; Cao Y; Gu H; Yu B
J Biomed Inform; 2022 Sep; 133():104173. PubMed ID: 35998815
[TBL] [Abstract] [Full Text] [Related]
18. A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors.
Sonehara K; Kimura Y; Nakano Y; Ozawa T; Takahashi M; Suzuki K; Fujii T; Matsushita Y; Tomiyama A; Kishikawa T; Yamamoto K; Naito T; Suzuki T; Yamaguchi S; Miwa T; Sasaki H; Kitagawa M; Ohe N; Fukai J; Ogiwara H; Kawamura A; Miyawaki S; Matsuda F; Kiyokawa N; Ichimura K; Nishikawa R; Okada Y; Terashima K
Nat Commun; 2022 Aug; 13(1):4478. PubMed ID: 35918310
[TBL] [Abstract] [Full Text] [Related]
19. Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma.
Verma A; Rafiq S
Cancer Treat Res; 2022; 183():161-184. PubMed ID: 35551659
[TBL] [Abstract] [Full Text] [Related]
20. The role of frailty in the clinical management of neurofibromatosis type 1: a mixed-effects modeling study using the Nationwide Readmissions Database.
Shahrestani S; Brown NJ; Strickland BA; Bakhsheshian J; Ghodsi SM; Nasrollahi T; Borrelli M; Gendreau J; Ruzevick JJ; Zada G
Neurosurg Focus; 2022 May; 52(5):E3. PubMed ID: 35535825
[TBL] [Abstract] [Full Text] [Related]
[Next]
